retatrutide clinical data Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials This data from Phase 3

Real Results: A patient experiencing significant hair loss had her doctor order basic labs that came back normal. Frustrated, she sought a second opinion from a dermatologist who ordered comprehensive testing

Sculptra for face and body laxity Sculptra for face and body laxity Sculptra is a biostimulator that supports gradual collagen stimulation, which can help restore structure in the face and improve skin quality over time

Glucagon-like peptide-1 suppresses neuroin flammation and improves neural structure

If you need to stop taking a GLP-1 medication whether due to cost, availability, or side effects gradually tapering off the medication may help minimize rebound hunger and weight regain